RxNorm 1251919

rotigotine 0.333 MG/HR

RxNorm Semantic Concepts

RxNorm semantic concepts for the RxCUI 1251919 unique identifier include: rotigotine 0.333 MG/HR (12283908).

RxNorm Atom ID: 12283908 - Semantic Clinical Drug Component
rotigotine 0.333 MG/HR

RXCUI:
1251919 - RxNorm Unique Identifier for a concept (Concept ID)
LAT:
ENG - Language of the Term
RXAUI:
12283908 - Unique identifier for the atom (RxNorm Atom ID)
Is Prescribable?
YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Concept Description:
rotigotine 0.333 MG/HR - Description of concept identifier
Term Type (TTY):
SCDC - Term type in source with name and description
Term Type Name:
Semantic Clinical Drug Component - Name of term type in source
Term Type Description:
Ingredient + Strength - Description of term type in source
Code:
1251919 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Suppress Flag:
N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF:
4096 - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
Source:
RXNORM - Concept source abbreviation
Source Name:
RxNorm Vocabulary - The official name for a source
Source Version:
20AA_240304F - The source version
Source Date:
March 04, 2024 - RxNorm data last updated
Source License Contact:
RxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source license contact information
Source Content Contact:
RxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source content contact information
Source Short Name:
RxNorm work done by the National Library of Medicine - The short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom 12283908 Attributes

PropertyValueExplanation
RXN BOSS STRENGTH DENOM UNITHRRXN Boss Strength Denom Unit
RXN BOSS STRENGTH DENOM VALUE1RXN Boss Strength Denom Value
RXN BOSS STRENGTH NUM UNITMGRXN Boss Strength Num Unit
RXN BOSS STRENGTH NUM VALUE0.333RXN Boss Strength Num Value
RXN STRENGTH0.333 MG/HRStrength plus unit of SCDC

* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Patient Education

Rotigotine Transdermal Patch


Rotigotine transdermal patches are used to treat the signs and symptoms of Parkinson's disease (PD; a disorder of the nervous system that causes difficulties with movement, muscle control, and balance) including shaking of parts of the body, stiffness, slowed movements, and problems with balance. Rotigotine transdermal patches are also used to treat restless legs syndrome (RLS or Ekbom syndrome; a condition that causes discomfort in the legs and a strong urge to move the legs, especially at night and when sitting or lying down). Rotigotine is in a class of medications called dopamine agonists. It works by acting in place of dopamine, a natural substance produced in the brain that is needed to control movement.
[Learn More]


* Please review the disclaimer below.